Literature DB >> 1397101

Differential proliferative response of cultured fetal and regenerating hepatocytes to growth factors and hormones.

C de Juan1, M Benito, A Alvarez, I Fabregat.   

Abstract

Upon epidermal growth factor (EGF) stimulation, fetal (20 days of gestation) and regenerating (44-48 h after partial hepatectomy) rat hepatocytes, isolated and cultured under identical conditions, increased DNA synthesis and entered into S-phase and mitosis, measured as [3H]thymidine incorporation and DNA content per nucleus in a flow cytometer, respectively. Fetal hepatocytes consisted of a homogeneous population of diploid (2C) cells. Two different populations of cells were present in regenerating liver, diploid (2C) and tetraploid (4C) cells, that responded to EGF. Glucagon or norepinephrine did not affect EGF stimulation of DNA synthesis in fetal liver cells, but they potentiated EGF response in regenerating hepatocyte cultures. Glucocorticoid hormones (dexamethasone) inhibited DNA synthesis in fetal hepatocyte cultures, an effect potentiated by the presence of glucagon or norepinephrine. In contrast, in regenerating hepatocytes, dexamethasone increased EGF-induced proliferation. EGF-dependent DNA synthesis was inhibited by TGF-beta in both fetal and regenerating cultured hepatocytes. TGF-beta action was partially suppressed by norepinephrine in regenerating hepatocytes, but was without effect in fetal hepatocyte cultures, whereas a synergistic action between TGF-beta and dexamethasone inhibiting growth in fetal but not in regenerating hepatocytes was found. Taken together, these results may suggest that there are significant differences between fetal and regenerating hepatocyte growth in their response to various hormones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397101     DOI: 10.1016/0014-4827(92)90104-g

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 3.  ALR and liver regeneration.

Authors:  Rafał Pawlowski; Jolanta Jura
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

4.  Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.

Authors:  Joan Fernando; Patricia Sancho; Conrado M Fernández-Rodriguez; José L Lledó; Laia Caja; Jean S Campbell; Nelson Fausto; Isabel Fabregat
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

5.  c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver.

Authors:  Esther Baena; Alberto Gandarillas; Mireia Vallespinós; Jennifer Zanet; Oriol Bachs; Clara Redondo; Isabel Fabregat; Carlos Martinez-A; Ignacio Moreno de Alborán
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-27       Impact factor: 11.205

6.  Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro.

Authors:  Gaelle del Castillo; Valentina M Factor; Margarita Fernández; Alberto Alvarez-Barrientos; Isabel Fabregat; Snorri S Thorgeirsson; Aránzazu Sánchez
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

7.  Establishment and characterization of feeder cell-dependent bovine fetal liver cell lines.

Authors:  Neil C Talbot; Ling Wang; Wesley M Garrett; Thomas J Caperna; Young Tang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-10       Impact factor: 2.416

8.  A continuous culture of pluripotent fetal hepatocytes derived from the 8-day epiblast of the pig.

Authors:  N C Talbot; C E Rexroad; A M Powell; V G Pursel; T J Caperna; S L Ogg; N D Nel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

9.  EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration.

Authors:  Alexandra Collin de L'hortet; Hélène Gilgenkrantz; Jacques-Emmanuel Guidotti
Journal:  Int J Hepatol       Date:  2012-09-23

10.  BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.

Authors:  Blanca Herrera; María García-Álvaro; Silvia Cruz; Peter Walsh; Margarita Fernández; Cesáreo Roncero; Isabel Fabregat; Aránzazu Sánchez; Gareth J Inman
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.